| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 163.07B | 163.02B | 160.05B | 141.85B | 124.66B | 114.72B |
| Gross Profit | 25.80B | 28.08B | 24.67B | 20.16B | 17.39B | 14.78B |
| EBITDA | 18.64B | 20.57B | 18.29B | 14.42B | 11.39B | 9.19B |
| Net Income | 11.87B | 12.85B | 11.56B | 8.30B | 7.91B | 5.33B |
Balance Sheet | ||||||
| Total Assets | 155.41B | 203.85B | 181.12B | 168.12B | 149.70B | 136.67B |
| Cash, Cash Equivalents and Short-Term Investments | 32.56B | 20.57B | 15.71B | 16.38B | 13.61B | 25.79B |
| Total Debt | 3.43B | 20.47B | 10.66B | 10.78B | 5.88B | 982.64M |
| Total Liabilities | 35.11B | 69.87B | 60.34B | 56.63B | 46.21B | 38.14B |
| Stockholders Equity | 119.10B | 132.67B | 119.62B | 110.43B | 102.38B | 97.13B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.19B | 2.48B | 973.22M | -14.45B | -3.12B |
| Operating Cash Flow | 0.00 | 5.24B | 4.16B | 4.84B | -8.96B | 3.09B |
| Investing Cash Flow | 0.00 | -4.90B | -1.25B | -3.68B | -4.96B | -5.83B |
| Financing Cash Flow | 0.00 | 4.52B | -3.58B | 1.61B | 1.75B | -3.17B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥261.79B | 14.20 | 7.43% | 2.78% | 2.69% | -6.90% | |
78 Outperform | ¥656.39B | 16.46 | ― | 2.15% | 0.46% | 38.67% | |
69 Neutral | ¥219.96B | 11.85 | ― | 3.09% | 0.55% | 65.67% | |
65 Neutral | ¥213.85B | 8.91 | ― | 3.82% | 7.97% | 37.15% | |
64 Neutral | ¥165.24B | 15.99 | ― | 2.87% | -1.92% | -12.16% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥148.55B | 11.44 | ― | 3.44% | 1.86% | 11.05% |